Proprietary AI analyst is now available

Carelabs Valuation Multiples

Discover Carelabs' revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Firefly Neuroscience, Cambridge Cognition, CareView Communications, ContextVision and more.

Carelabs Overview

About Carelabs

Carelabs Co Ltd engages in the provision of healthcare information technology services. The company provides clinic information, clinic customer management software, and digital marketing solutions. Its healthcare media platform includes GoodDak, a mobile medical information service; and Barbietk, a healthcare service that shares domestic cosmetic, skin care, and diet reviews.


Founded

2012

HQ

South Korea

Employees

120

Financials (FY)

Revenue: $53M
EBITDA: $18M

EV

$1M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Carelabs Financials

Carelabs reported last fiscal year revenue of $53M and EBITDA of $18M.

In the same fiscal year, Carelabs generated $52M in gross profit, $18M in EBITDA, and $13M in net income.


Carelabs P&L

In the most recent fiscal year, Carelabs reported revenue of $53M and EBITDA of $18M.

Carelabs is profitable as of last fiscal year, with gross margin of 98%, EBITDA margin of 34%, and net margin of 23%.

See analyst estimates for Carelabs
Last FY202320242025202620272028
Revenue$53M$53M$54M$53M
Gross Profit$52M$52M$54M$52M
Gross Margin98%97%99%98%
EBITDA$18M($9M)($8M)$18M
EBITDA Margin34%(17%)(15%)34%
EBIT Margin(4%)(14%)(5%)(4%)
Net Profit$13M($16M)($13M)$13M
Net Margin23%(30%)(24%)23%

Financial data powered by Morningstar, Inc.

Carelabs Stock Performance

Carelabs has current market cap of $24M, and enterprise value of $1M.

Market Cap Evolution


Carelabs' stock price is $1.26.

Carelabs share price decreased by 8.5% in the last 30 days, and by 45.4% in the last year.

Carelabs has an EPS (earnings per share) of $0.64.

See more trading valuation data for Carelabs
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1M$24M-3.1%-8.5%-18.9%-45.4%$0.64

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Carelabs Valuation Multiples

Carelabs trades at 0.0x EV/Revenue multiple, and 0.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Carelabs

Carelabs Financial Valuation Multiples

As of June 6, 2026, Carelabs has market cap of $24M and EV of $1M.

Carelabs has a P/E ratio of 2.0x.

Last FY202320242025202620272028
EV/Revenue0.0x0.0x0.0x0.0x
EV/EBITDA0.1x(0.2x)(0.2x)0.1x
EV/EBIT(0.8x)(0.2x)(0.5x)(0.8x)
EV/Gross Profit0.0x0.0x0.0x0.0x
P/E2.0x(1.5x)(1.8x)2.0x
EV/FCF(0.1x)(0.2x)(0.5x)(0.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Carelabs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Carelabs Margins & Growth Rates

In the most recent fiscal year, Carelabs reported gross margin of 98%, EBITDA margin of 34%, and net margin of 23%.

See estimated margins and future growth rates for Carelabs

Carelabs Margins

Last FY20242025202720282029
Gross Margin98%99%98%
EBITDA Margin34%(15%)34%
EBIT Margin(4%)(5%)(4%)
Net Margin23%(24%)23%
FCF Margin(19%)(5%)(19%)

Carelabs Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth2%(2%)
Gross Profit Growth3%(2%)
EBITDA Growth(13%)(324%)
EBIT Growth(62%)(36%)
Net Profit Growth(17%)(195%)
FCF Growth(65%)250%

Data powered by FactSet, Inc. and Morningstar, Inc.

Carelabs Operational KPIs

Carelabs' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.5M for the same period.

Access forward-looking KPIs for Carelabs
Last FY202320242025202620272028
Revenue per Employee$0.4M---
Opex per Employee$0.5M---
S&M Expenses to Revenue57%67%63%57%
G&A Expenses to Revenue3%4%3%3%
R&D Expenses to Revenue3%5%3%3%
Opex to Revenue102%112%104%102%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Firefly Neuroscience20.7x-(1.2x)-
Cambridge Cognition1.8x1.6x(33.8x)(110.1x)
CareView Communications----
ContextVision1.8x1.8x9.5x9.5x
EBM Technologies2.2x-19.4x-
Beamtree0.9x1.2x(84.7x)(84.7x)
Diagnos230.9x-(6.8x)-
MRSO1.0x1.0x(38.4x)-

This data is available for Pro users. Sign up to see all Carelabs competitors and their valuation data.

Start Free Trial

Acquisitions by Carelabs

Carelabs has acquired 2 companies to date.

Last acquisition by Carelabs was on July 16th 2019. Carelabs acquired Eunogo for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Carelabs

Eunogo
BNKLAB
Description
-
BNKLAB is a Seoul-based mobile app developer and publisher specializing in social discovery platforms for dating and networking. The company operates the 'BNK' app, which uses location-based matching and video profiles to connect over 500,000 users in South Korea. Launched in 2019, BNKLAB integrates gamified features and safety verification to facilitate real-world meetups among young professionals.
HQ CountrySingaporeSouth Korea
HQ City
Singapore
Seoul
Deal Date16 Jul 201910 Jul 2018
Valuationundisclosed$10M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Carelabs acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Carelabs

Carelabs has invested in 5 companies to date.

Latest investment by Carelabs was on May 12th 2023. Carelabs invested in Humanscape in their $15M Series C round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Carelabs

Humanscape
Goodoc
Brain Gear
Brain Gear
Description
Humanscape is a Seoul-headquartered health-tech firm focused on rare disease data platforms since 2018. The company aggregates genotype, clinical, and phenotype data from 100,000 patients across 500 diseases, enabling pharma partners like Novartis to accelerate drug trials by 30 percent. Its blockchain-secured database supports AI model training for precision medicine. Humanscape operates in South Korea, the United States, and Japan, with integrations to EHRs from Allscripts and Cerner. The platform has facilitated 20 investigational new drug applications.
-
Brain Gear is a medical device manufacturer producing light-therapy systems for neurological conditions. Based in Europe, the company offers wearable devices emitting specific wavelengths for migraine relief and cognitive enhancement. Dagear.net details FDA-cleared photobiomodulation units. Brain Gear targets treatments for traumatic brain injury and depression. Its systems use near-infrared light delivered through helmets and panels.
Brain Gear is a medical device manufacturer producing light-therapy systems for neurological conditions. Based in Europe, the company offers wearable devices emitting specific wavelengths for migraine relief and cognitive enhancement. Dagear.net details FDA-cleared photobiomodulation units. Brain Gear targets treatments for traumatic brain injury and depression. Its systems use near-infrared light delivered through helmets and panels.
HQ CountrySouth KoreaSouth KoreaSouth KoreaSouth Korea
HQ City
Seoul
-
Daejeon
Daejeon
Deal Date12 May 20239 May 202218 Jan 20224 Aug 2021
RoundSeries CSeries ASeries ASeries A
Raised$15M$17M$2M$2M
InvestorsCarelabs; GC Biopharma; Hana Securities; Kyobo Securities; Mint Venture Partners; Shinhan Asset Management; Shinhan Bank; UTC InvestmentBokwang Investment; Carelabs; Dt& Investment; E&Venture Partners; Industrial Bank of Korea; KB Investment; Magellan Technology Investment; Samsung Venture Investment; TINVESTMENTBigbang Angels; Carelabs; Center for Creative Economy and Innovation; CNTTECHBigbang Angels; Carelabs
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Carelabs investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Carelabs

When was Carelabs founded?Carelabs was founded in 2012.
Where is Carelabs headquartered?Carelabs is headquartered in South Korea.
How many employees does Carelabs have?As of today, Carelabs has over 120 employees.
Is Carelabs publicly listed?Yes, Carelabs is a public company listed on Korea Exchange.
What is the stock symbol of Carelabs?Carelabs trades under 263700 ticker.
When did Carelabs go public?Carelabs went public in 2018.
Who are competitors of Carelabs?Carelabs main competitors include Firefly Neuroscience, Cambridge Cognition, CareView Communications, ContextVision, EBM Technologies, Beamtree, Diagnos, MRSO, CurveBeam AI, NextPlat.
What is the current market cap of Carelabs?Carelabs' current market cap is $24M.
What is the current revenue of Carelabs?Carelabs' last fiscal year revenue is $53M.
What is the current EV/Revenue multiple of Carelabs?Current revenue multiple of Carelabs is 0.0x.
Is Carelabs profitable?No, Carelabs is not profitable.
How many companies Carelabs has acquired to date?As of June 2026, Carelabs has acquired 2 companies.
What was the largest acquisition by Carelabs?$10M acquisition of BNKLAB on 10th July 2018 was the largest M&A Carelabs has done to date.
What companies Carelabs acquired?Carelabs acquired BNKLAB and Eunogo.
In how many companies Carelabs has invested to date?As of June 2026, Carelabs has invested in 5 companies.
What was the last Carelabs investment?On 12th May 2023 Carelabs invested in Humanscape, participating in a $15M Series C round, alongside GC Biopharma, Hana Securities, Kyobo Securities, Mint Venture Partners, Shinhan Asset Management, Shinhan Bank, and UTC Investment.
In what companies Carelabs invested in?Carelabs invested in Goodoc, Humanscape, Medi Staff, Sphere, and Brain Gear.

See public comps similar to Carelabs

Lists including Carelabs

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial